Back to search results

DeBakey Cardiovascular Magnetic Resonance Study

This observational study is looking at how Cardiovascular Magnetic Resonance (CMR) scans, which are special types of MRI scans that look at your heart and blood vessels, can help doctors understand and treat cardiovascular diseases. The study will include patients who come to the Houston Methodist CMR Laboratory with known or suspected heart conditions. Researchers want to see how CMR helps doctors make decisions and how it relates to long-term health outcomes like heart failure, the need for a heart or lung transplant, or even death. The goal is to use CMR to improve how patients with heart conditions are cared for.

Study design
This is an observational study planning to enroll up to 100,000 participants. It is not a randomized or blinded study.
What's involved
You would undergo various CMR techniques and have your medical history reviewed. A small blood sample will be drawn, and your health status will be followed annually for up to 20 years.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for their health status, including mortality, heart failure, and heart/lung transplantation, through study completion, which is an average of once a year for up to 20 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04281823

DeBakey Cardiovascular Magnetic Resonance Study

Recruiting
Not specifiedAll AgesObservational
Dipan Shah
~100,000 participants
Updated 2026-04-20 on ClinicalTrials.gov
What's tested:Cardiovascular Magnetic Resonance

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mortality
Measured over Through study completion, an average of once a year, up to 20 years
+3 more outcomes measured

Conditions

Cardiovascular Diseases

Explore related trials

CardiomyopathyCardiovascular DisorderIschemic Heart DiseaseValvular Heart Disorder

Where it's being run

1 sites across 1 states
Texas1

Study leadership

  • Dipan Shah, MD · PRINCIPAL_INVESTIGATOR · The Methodist Hospital Research Institute

Who to contact

Rachel Kronman-Gross, BS
[email protected]
7134416539
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All patients presenting to the Houston Methodist CMR Laboratory with known or suspected cardiovascular disease.

Exclusion

Unable to provide informed consent

What this trial measures

  • MortalityThrough study completion, an average of once a year, up to 20 years

    All-cause mortality, Cardiovascular mortality (acute Myocardial Infarction, sudden death, heart failure, cerebrovascular, procedural), and Non-cardiovascular mortality

  • Heart FailureThrough study completion, an average of once a year, up to 20 years

    Congestive heart failure

  • Heart and/or Lung TransplantationThrough study completion, an average of once a year, up to 20 years
  • Left Ventricular and/or Right Ventricular Assist Device ImplantationThrough study completion, an average of once a year, up to 20 years